All 20 assets are trading higher. Leaders: RENDER (+13.5%) and ETC (+11.3%). Laggards: BTC (+2.4%) and ETH (+2.6%). The <a ...
The recently published article in Science by the Genentech team presents the structure of CD20 in complex with the therapeutic monoclonal antibody RTX. This study underscores the significance of ...
TipRanks on MSN13d
ImmuneOnco Biopharmaceuticals Advances Lupus Treatment TrialsImmuneOnco Biopharmaceuticals has received approval from China’s National Medical Products Administration for a Phase II ...
Medpage Today on MSN4d
Tafasitamab-Based Combination Boosts PFS in Relapsed/Refractory Follicular LymphomaAdding the humanized CD19-targeted monoclonal antibody tafasitamab (Monjuvi) to a backbone of lenalidomide (Revlimid) and ...
Avalanche, the layer-1 blockchain that is upgrading its technology platform, has raised $250 million in a token sale led by ...
The non-cryopreserved CD19- and CD20-directed CAR T-cell therapy zamto-cel is manufactured in a closed-system device that ...
Ordspono is a CD20xCD3 bispecific monoclonal antibody that facilitates T cell engagement for the targeted killing of ...
In a presentation at the recent American Society of Hematology meeting in San Diego, Kite Pharma Inc. reported preclinical data for KITE-753, an autologous rapid manufactured anti-CD19/CD20 CAR T-cell ...
The CoinDesk 20 is currently trading at 3830.63, down 0.2% (-7.76) since 4 p.m. ET on Thursday. Six of 20 assets are trading ...
With a median follow-up of 14.1 months, adding tafasitamab to lenalidomide and rituximab reduced the risk of progression, ...
The data published shows that IPH6501, also called CD20-NKCE-IL2v in the publication, boosts NK cell proliferation and cytotoxicity, showing activity against a range of B-NHL cell lines ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback